רספרים

Country: Израел

Језик: Хебрејски

Извор: Ministry of Health

Активни састојак:

SULPHAMETHOXAZOLE; TRIMETHOPRIM

Доступно од:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

АТЦ код:

J01EE01

Фармацеутски облик:

תרחיף

Састав:

SULPHAMETHOXAZOLE 200 MG / 5 ML; TRIMETHOPRIM 40 MG / 5 ML

Пут администрације:

פומי

Тип рецептора:

מרשם נדרש

Произведен од:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Терапеутска група:

SULFAMETHOXAZOLE AND TRIMETHOPRIM

Терапеутска област:

SULFAMETHOXAZOLE AND TRIMETHOPRIM

Терапеутске индикације:

Treatment of urinary tract infections due to susceptible strains of the following organisms: - Escherichia coli - Klebsiella - Enterobacter - Proteus mirabilis - Proteus vulgaris - Proteus morganii. Treatment of acute otitis media in children due to susceptible strains of Haemophilus influenzae or Streptococcus pneumoniae. To date there are limited data available as to the safety of repeated use of Resprim in infants under 2 years of age. Resprim is not indicated for prophylactic or prolonged administration in otitis media at any age. Treatment of acute exacerbations of chronic bronchitis due to susceptible strains of Haemophilus influenzae or Streptococcus pneumoniae. Treatment of enteritis caused by susceptible strains of Shigella flexneri and Shigella sonnei. Resprim is also indicated in the treatment of documented Pneumocystis carinii pneumonitis.

Датум одобрења:

2012-01-31